isosorbide dinitrate has been researched along with sq-11725 in 40 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (7.50) | 18.7374 |
1990's | 9 (22.50) | 18.2507 |
2000's | 22 (55.00) | 29.6817 |
2010's | 6 (15.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Metelitsa, VI | 1 |
Mir, MA; Tirlapur, VG | 2 |
Amodio, P; Angeli, P; Cavallarin, G; Donada, C; Enzo, E; Gatta, A; Marin, R; Merkel, C; Sebastianelli, G; Torboli, P | 1 |
Bellon, S; Bolognesi, M; Caregaro, L; Gatta, A; Merkel, C; Sacerdoti, D | 1 |
Bolognesi, M; Gatta, A; Merkel, C; Sacerdoti, D | 1 |
Balanzó, J; Cussó, X; Guarner, C; Novella, MT; Sáinz, S; Soriano, G; Torras, X; Vilardell, F; Villanueva, C | 1 |
Chambliss, ML; Stevermer, JJ | 1 |
García-Tsao, G | 1 |
Angeli, P; Bolognesi, M; Bombonato, G; Enzo, E; Gatta, A; Marin, R; Merkel, C; Sacerdoti, D | 1 |
Bolognesi, M; Bombonato, G; Gatta, A; Merkel, C; Sacerdoti, D | 1 |
Amodio, P; Angeli, P; Bolognesi, M; Buonamico, P; Gatta, A; Merkel, C; Micotti, L; Sacerdoti, D; Sticca, A | 1 |
Amodio, P; Bolognesi, M; Cavallarin, G; Donada, C; Felder, M; Gatta, A; Marin, R; Mazzaro, C; Merkel, C; Sacerdoti, D; Sebastianelli, G; Torboli, P | 1 |
Bosch, J | 1 |
Bellini, B; Bighin, R; Bolognesi, M; Bombonato, G; Gatta, A; Merkel, C; Sacerdoti, D | 1 |
Herrera, JL; Zalepuga, R | 1 |
Balanzó, J; Boadas, J; Cussó, X; Gallego, A; Guarner, C; Miñana, J; Ortiz, J; Sáinz, S; Soriano, G; Torras, X; Villanueva, C | 1 |
Lock, G; Messmann, H; Wiest, R | 1 |
Bissoli, F; Borroni, G; Cazzaniga, M; de Franchis, R; Lorenzano, E; Maggi, A; Panzeri, A; Salerno, F; Visentin, S | 1 |
Barkin, JS; Maldonado, D | 1 |
Chen, MH; Chen, WC; Hsu, PI; Lai, KH; Lin, CK; Lo, GH; Tsai, WL | 1 |
Aracil, C; Balanzó, J; González, B; Guarner, C; Kolle, L; López-Balaguer, JM; Miñana, J; Soriano, G; Villanueva, C | 1 |
Bhaskar, ME | 1 |
Gupta, R; Sarin, SK; Shahi, H; Wadhawan, M | 1 |
Balanzo, J; Cusso, X; Gallego, A; Gonzalez-Suarez, B; Guarner, C; Minana, J; Sainz, S; Soriano, G; Torras, X; Villanueva, C | 1 |
Argonz, J; Bosco, A; Dominguez, N; Fassio, E; Kravetz, D; Muñoz, A; Romero, G; Salgado, P; Suarez, A; Terg, R; Vulcano, C | 1 |
Laleman, W; Nevens, F | 1 |
Chan, HH; Chen, WC; Cheng, LC; Hsu, PI; Lai, KH; Lo, GH; Tsai, WL; Wang, HM | 1 |
Chan, HH; Chen, TA; Chen, WC; Hsu, PI; Lai, KH; Lin, CK; Lo, GH; Tsai, WL; Yu, HC | 1 |
Aracil, C; Balanzo, J; Colomo, A; Gonzalez, B; Guarner, C; Lopez-Balaguer, JM; Piqueras, M; Torras, X; Villanueva, C | 1 |
Abraldes, JG; Albillos, A; Bañares, R; Bosch, J; García-Pagán, JC; Morillas, R; Villanueva, C | 1 |
Chan, HH; Chen, TA; Chen, WC; Hsu, PI; Lai, KH; Lin, CK; Lo, GH; Tsai, WL | 1 |
Abu-Suboh, M; Armengol, JR; Augustin, S; Dot, J; Esteban, R; Genescà, J; González, A; Guardia, J; Pérez, M; Romero, A; Segarra, A | 1 |
Chen, WC; Lo, GH; Wang, HM; Yu, HC | 1 |
Bai, M; Fan, D; Han, G; Qi, X; Yang, M | 1 |
3 review(s) available for isosorbide dinitrate and sq-11725
Article | Year |
---|---|
The sixth Carlos E. Rubio Memorial Lecture. Prevention and treatment of variceal hemorrhage.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Double-Blind Method; Drug Therapy, Combination; Endoscopy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Ligation; Liver Transplantation; Lypressin; Middle Aged; Mineralocorticoid Receptor Antagonists; Nadolol; Nitric Oxide Donors; Nitroglycerin; Portasystemic Shunt, Transjugular Intrahepatic; Propranolol; Randomized Controlled Trials as Topic; Recurrence; Sclerotherapy; Spironolactone; Terlipressin; Vasoconstrictor Agents; Vasodilator Agents | 2000 |
Cirrhotic portal hypertension: current and future medical therapy for primary and secondary prevention of variceal bleeding.
Topics: Adrenergic beta-Antagonists; Animals; Contraindications; Drug Therapy, Combination; Endoscopy; Esophageal and Gastric Varices; Follow-Up Studies; Forecasting; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Middle Aged; Nadolol; Portasystemic Shunt, Surgical; Portasystemic Shunt, Transjugular Intrahepatic; Practice Guidelines as Topic; Propranolol; Randomized Controlled Trials as Topic; Rats; Risk Factors; Risk Reduction Behavior; Splanchnic Circulation; Stents; Time Factors; Vascular Resistance; Vasodilator Agents | 2006 |
Combined therapies versus monotherapies for the first variceal bleeding in patients with high-risk varices: a meta-analysis of randomized controlled trials.
Topics: Combined Modality Therapy; Databases, Bibliographic; Drug Therapy, Combination; Endpoint Determination; Esophageal and Gastric Varices; Follow-Up Studies; Gastrointestinal Hemorrhage; Gastroscopy; Humans; Isosorbide Dinitrate; Nadolol; Propranolol; Randomized Controlled Trials as Topic; Risk; Spironolactone | 2014 |
23 trial(s) available for isosorbide dinitrate and sq-11725
Article | Year |
---|---|
A comparison of nifedipine and isosorbide dinitrate in angina pectoris with particular reference to arterial oxygen saturation.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Drug Therapy, Combination; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nadolol; Nifedipine; Oxygen; Partial Pressure; Propanolamines; Pyridines | 1983 |
Long-term effect of nadolol or nadolol plus isosorbide-5-mononitrate on renal function and ascites formation in patients with cirrhosis. GTIP Gruppo Triveneto per l'Ipertensione Portale.
Topics: Adolescent; Adult; Aged; Ascites; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Humans; Isosorbide Dinitrate; Kidney; Liver Cirrhosis; Longitudinal Studies; Male; Middle Aged; Nadolol; Venous Pressure | 1995 |
Duplex Doppler ultrasonography allows a multiorgan noninvasive approach to splanchnic pharmacodynamics in patients with cirrhosis.
Topics: Administration, Oral; Adult; Aged; Blood Flow Velocity; Blood Pressure; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Kidney; Liver; Liver Cirrhosis; Male; Mesenteric Artery, Superior; Middle Aged; Nadolol; Pulsatile Flow; Splanchnic Circulation; Ultrasonography, Doppler, Color; Vascular Resistance; Vasodilator Agents | 1995 |
Duplex Doppler sonographic evaluation of splanchnic and renal effects of single agent and combined therapy with nadolol and isosorbide-5-mononitrate in cirrhotic patients.
Topics: Adult; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Nadolol; Renal Circulation; Splanchnic Circulation; Ultrasonography, Doppler, Duplex; Vasodilator Agents | 1994 |
Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding.
Topics: Actuarial Analysis; Adrenergic beta-Antagonists; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nadolol; Recurrence; Sclerotherapy; Survival Analysis; Treatment Outcome; Vasodilator Agents | 1996 |
Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the beta-blocker alone.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Female; Heart Rate; Hemodynamics; Hepatic Artery; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver; Liver Cirrhosis; Male; Middle Aged; Nadolol; Vasodilator Agents | 1997 |
Doppler sonography and hepatic vein catheterization in portal hypertension: assessment of agreement in evaluating severity and response to treatment.
Topics: Adrenergic beta-Antagonists; Catheterization, Peripheral; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Hepatic Veins; Humans; Hypertension, Portal; Isosorbide Dinitrate; Linear Models; Liver Cirrhosis; Male; Middle Aged; Nadolol; Treatment Outcome; Ultrasonography, Doppler, Duplex; Vasodilator Agents | 1998 |
Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Ascites; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Nadolol; Randomized Controlled Trials as Topic | 2000 |
Should nitrates be used with beta blockers to prevent variceal bleeding?
Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Liver Cirrhosis; Nadolol; Vasodilator Agents | 2000 |
Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding.
Topics: Actuarial Analysis; Adrenergic beta-Antagonists; Drug Therapy, Combination; Endoscopy; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Isosorbide Dinitrate; Ligation; Male; Middle Aged; Nadolol; Postoperative Complications; Regression Analysis; Secondary Prevention; Survival Analysis; Vasodilator Agents | 2001 |
Nadolol is superior to isosorbide mononitrate for the prevention of the first variceal bleeding in cirrhotic patients with ascites.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Ascites; Blood Pressure; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Heart Rate; Humans; Isosorbide Dinitrate; Kidney; Liver Cirrhosis; Male; Middle Aged; Nadolol; Survival Rate; Treatment Outcome; Vasodilator Agents | 2002 |
Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding.
Topics: Adult; Antihypertensive Agents; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Male; Middle Aged; Nadolol; Secondary Prevention; Treatment Failure; Vasodilator Agents | 2002 |
Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis.
Topics: Adrenergic beta-Antagonists; Aged; Ascites; Esophageal and Gastric Varices; Female; Hemodynamics; Hepatic Encephalopathy; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Circulation; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Nadolol; Prognosis | 2004 |
Evaluation of endoscopic variceal ligation (EVL) versus propanolol plus isosorbide mononitrate/nadolol (ISMN) in the prevention of variceal rebleeding: comparison of cirrhotic and noncirrhotic patients.
Topics: Adult; Antihypertensive Agents; Drug Therapy, Combination; Endoscopy, Digestive System; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Male; Middle Aged; Nadolol; Propranolol; Secondary Prevention; Vasodilator Agents | 2005 |
Pharmacologic treatment of portal hypertension in the prevention of community-acquired spontaneous bacterial peritonitis.
Topics: Adrenergic beta-Antagonists; Bacterial Infections; Community-Acquired Infections; Drug Therapy, Combination; Epidemiologic Methods; Esophageal and Gastric Varices; Esophagoscopy; Female; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Ligation; Male; Middle Aged; Nadolol; Peritonitis; Sclerotherapy; Secondary Prevention; Vasodilator Agents | 2006 |
Comparative study between nadolol and 5-isosorbide mononitrate vs. endoscopic band ligation plus sclerotherapy in the prevention of variceal rebleeding in cirrhotic patients: a randomized controlled trial.
Topics: Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Male; Middle Aged; Nadolol; Sclerotherapy; Secondary Prevention | 2006 |
Comparison of endoscopic variceal ligation and nadolol plus isosorbide-5-mononitrate in the prevention of first variceal bleeding in cirrhotic patients.
Topics: Adult; Aged; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Male; Middle Aged; Nadolol | 2006 |
Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Digestive System Surgical Procedures; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Kaplan-Meier Estimate; Ligation; Male; Middle Aged; Nadolol; Secondary Prevention; Treatment Outcome; Vasodilator Agents | 2008 |
Clinical trial: a randomized controlled study on prevention of variceal rebleeding comparing nadolol + ligation vs. hepatic venous pressure gradient-guided pharmacological therapy.
Topics: Antihypertensive Agents; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Male; Middle Aged; Nadolol; Secondary Prevention; Venous Pressure | 2009 |
Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicentre randomised controlled trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Combined Modality Therapy; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Male; Middle Aged; Nadolol; Prospective Studies; Secondary Prevention; Survival Analysis; Treatment Outcome; Vasodilator Agents | 2009 |
A randomized, controlled trial of banding ligation plus drug therapy versus drug therapy alone in the prevention of esophageal variceal rebleeding.
Topics: Adrenergic beta-Antagonists; Chi-Square Distribution; Combined Modality Therapy; Esophageal and Gastric Varices; Female; Humans; Isosorbide Dinitrate; Ligation; Male; Middle Aged; Nadolol; Proportional Hazards Models; Recurrence; Treatment Outcome; Vasodilator Agents | 2009 |
Adding banding ligation is effective as rescue therapy to prevent variceal rebleeding in haemodynamic non-responders to pharmacological therapy.
Topics: Acute Disease; Aged; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Male; Middle Aged; Nadolol; Secondary Prevention; Somatostatin; Treatment Outcome | 2012 |
Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Carbazoles; Carvedilol; Chi-Square Distribution; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hemostasis, Endoscopic; Humans; Hypertension, Portal; Isosorbide Dinitrate; Kaplan-Meier Estimate; Ligation; Male; Middle Aged; Nadolol; Propanolamines; Proportional Hazards Models; Secondary Prevention; Vasodilator Agents | 2012 |
14 other study(ies) available for isosorbide dinitrate and sq-11725
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
[Drugs in secondary prevention of ischemic heart disease: achievements, problems and prospects].
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Coronary Disease; Female; Humans; Isosorbide Dinitrate; Male; Metoprolol; Nadolol; Nifedipine; Nitrates; Nitroglycerin; Propranolol; Verapamil | 1989 |
Cardiorespiratory effects of isosorbide dinitrate and nifedipine in combination with nadolol: a double-blind comparative study of beneficial and adverse antianginal drug interactions.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nadolol; Nifedipine; Oxygen; Physical Exertion; Propanolamines; Random Allocation; Respiration; Respiratory Function Tests | 1984 |
Prevention of variceal rebleeding.
Topics: Acute Disease; Adrenergic beta-Antagonists; Diuretics, Osmotic; Drug Combinations; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Nadolol; Randomized Controlled Trials as Topic; Recurrence; Reproducibility of Results; Sclerotherapy; Treatment Outcome | 1996 |
Further evidence in favor of pharmacological portal pressure reduction in the prevention of variceal hemorrhage.
Topics: Antihypertensive Agents; Drug Therapy, Combination; Hemorrhage; Humans; Isosorbide Dinitrate; Nadolol; Prospective Studies; Randomized Controlled Trials as Topic; Sclerotherapy; Varicose Veins; Vasodilator Agents | 1997 |
Effect of chronic treatment with nadolol plus isosorbide mononitrate on liver blood flow and liver metabolic activity in cirrhosis.
Topics: Adrenergic beta-Antagonists; Coloring Agents; Delayed-Action Preparations; Drug Therapy, Combination; Female; Hepatic Veins; Humans; Indocyanine Green; Isosorbide Dinitrate; Liver; Liver Circulation; Liver Cirrhosis; Male; Metabolic Clearance Rate; Middle Aged; Nadolol; Nitric Oxide Donors; Venous Pressure | 1999 |
The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Hemodynamics; Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Nadolol; Prognosis; Vasodilator Agents | 2000 |
[Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding].
Topics: Drug Therapy, Combination; Esophageal and Gastric Varices; Esophagoscopy; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Nadolol; Randomized Controlled Trials as Topic; Recurrence | 2002 |
Combined therapy for secondary prophylaxis of variceal rebleeding?
Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Endoscopy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Isosorbide Dinitrate; Ligation; Nadolol; Postoperative Complications; Randomized Controlled Trials as Topic; Recurrence; Survival Analysis; Vasodilator Agents | 2002 |
Management of cirrhosis and ascites.
Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Liver Cirrhosis; Nadolol; Propranolol; Secondary Prevention; Vasodilator Agents | 2004 |